ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.
NYS Entity Status
NYS Filing Date
JANUARY 24, 2013
NYS DOS ID#
CORPORATION SERVICE COMPANY
80 STATE STREET
ALBANY, NEW YORK, 12207
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - E.T. ELECTRICAL CONTRACTING COMPANY, INC.
Around the Web
- NY AG presses TransUnion, Experian for cybersecurity details
By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017
- Tesla in Talks to Set Up Electric Car Factory in Shanghai
By CARLOS TEJADA - Thursday Jun 22, 2017
The company said foreign production was needed to make its models more affordable overseas. Its plan for a plant would require a Chinese partner.
- Tesla Quarterly Loss Grows to $400 Million as It Prepares for the Mass Market Model 3
By BILL VLASIC - Wednesday Aug 2, 2017
The electric-car maker lost more than $400 million in the second quarter, but its revenues doubled, with its first mass-market model in the offing.
- Economic Trends: To Understand Rising Inequality, Consider the Janitors at Two Top Companies, Then and Now
By NEIL IRWIN - Sunday Sep 3, 2017
Focusing on core competence and outsourcing the rest has made U.S. companies lean, nimble and productive. It has also left lots of people worse off.
- The Decline of the Baronial C.E.O.
By NELSON D. SCHWARTZ - Saturday Jun 17, 2017
Corporate giants once had all-powerful chiefs with domains to match. But activist investors and technological change are remaking the executive suite.
- Considering the Side Effects of Drugmakers’ Money-Back Guarantees
By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017
The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.